2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Colorectal Neoplasms, Hereditary Nonpolyposis
2
Colorectal Neoplasms
2
Recurrence
1
Psoriasis
1
Neoplasms
1
Lymphoma, Follicular
1
Inflammatory Bowel Diseases
1
Colonic Neoplasms
1
Colitis, Ulcerative
1
Adenoma
1
Interventions
Surveys and Questionnaires
10
Colonoscopy
6
Specimen Handling
5
Observation
4
Genetic Testing
4
Magnetic Resonance Spectroscopy
3
Interviews as Topic
3
High-Throughput Nucleotide Sequencing
3
Genetic Counseling
3
Endoscopy
3
Biopsy
3
Nivolumab
2
Naproxen
2
Mesalamine
2
Educational Status
2
Aspirin
2
toripalimab
1
tislelizumab
1
spartalizumab
1
pembrolizumab
1
dehydroftorafur
1
atezolizumab
1
acetylsalicylic acid lysinate
1
Telemedicine
1
Taxes
1
Secretin
1
Salpingo-oophorectomy
1
RAD51C protein, human
1
Physical Examination
1
Patient Navigation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Colorectal Neoplasms, Hereditary Nonpolyposis
×
Mesalamine
×
Clear all
NCT04920149
2024-12-17
MesaCAPP
Karolinska University Hospital
Phase 2
Recruiting
150 enrolled
NCT03070574
2019-04-18
MesaCAPP
Medical University of Vienna
Phase 2
Terminated
8 enrolled